These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 24579462)

  • 1. [Guidelines for the treatment of Hansen's disease in Japan (third edition)].
    Goto M; Nogam R; Okano Y; Gidoh M; Yotsu R; Ishida Y; Kitajima S; Kai M; Ishii N; Ozaki M; Hatano K; ;
    Nihon Hansenbyo Gakkai Zasshi; 2013 Dec; 82(3):143-84. PubMed ID: 24579462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Guideline for the treatment of Hansen's disease in Japan (Second edition)].
    Goto M; Nogami R; Hatano K; Okano Y; Ishii N; Gidoh M; Ishida Y; Ozaki M;
    Nihon Hansenbyo Gakkai Zasshi; 2006 Sep; 75(3):191-226. PubMed ID: 17037376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Guideline for the treatment of Hansen's disease in Japan].
    Goto M; Ishida Y; Gidoh M; Nagao E; Namisato M; Ishii N; Ozaki M;
    Nihon Hansenbyo Gakkai Zasshi; 2000 Nov; 69(3):157-77. PubMed ID: 11187723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Chemotherapy of leprosy: theoretical basis of new guideline in Japan].
    Goto M
    Nihon Hansenbyo Gakkai Zasshi; 2001 Aug; 70(3):151-5. PubMed ID: 11579514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uniform multidrug therapy for leprosy patients in Brazil (U-MDT/CT-BR): Results of an open label, randomized and controlled clinical trial, among multibacillary patients.
    Penna GO; Bührer-Sékula S; Kerr LRS; Stefani MMA; Rodrigues LC; de Araújo MG; Ramos AMC; de Andrade ARC; Costa MB; Rosa PS; Gonçalves HS; Cruz R; Barreto ML; Pontes MAA; Penna MLF
    PLoS Negl Trop Dis; 2017 Jul; 11(7):e0005725. PubMed ID: 28704363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical pilot study: Clarithromycin efficacy in multibacillary leprosy therapy.
    Gunawan H; Sasmojo M; Putri HE; Avriyanti E; Hindritiani R; Suwarsa O
    Int J Mycobacteriol; 2018; 7(2):152-155. PubMed ID: 29900892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined 12-month WHO/MDT MB regimen and Mycobacterium w. vaccine in multibacillary leprosy: a follow-up of 136 patients.
    Kaur I; Dogra S; Kumar B; Radotra BD
    Int J Lepr Other Mycobact Dis; 2002 Sep; 70(3):174-81. PubMed ID: 12483965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Daily multidrug therapy for leprosy; results of a fourteen-year experience.
    de Carsalade GY; Wallach D; Spindler E; Pennec J; Cottenot F; Flageul B
    Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):37-44. PubMed ID: 9207752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of multidrug therapy in multibacillary leprosy: a long-term follow-up of 34 multibacillary leprosy patients treated with multidrug regimens till skin smear negativity.
    Shaw IN; Christian M; Jesudasan K; Kurian N; Rao GS
    Lepr Rev; 2003 Jun; 74(2):141-7. PubMed ID: 12862255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MDT-MB therapy in paucibacillary leprosy: a clinicopathological assessment.
    Prasad PV; Babu A; Kaviarasan PK; Viswanathan P; Tippoo R
    Indian J Dermatol Venereol Leprol; 2005; 71(4):242-5. PubMed ID: 16394431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relapses among leprosy patients treated with multidrug therapy: experience in the leprosy control program of the All Africa Leprosy and Rehabilitation Training Center (ALERT) in Ethiopia; practical difficulties with diagnosing relapses; operational procedures and criteria for diagnosing relapses.
    Becx-Bleumink M
    Int J Lepr Other Mycobact Dis; 1992 Sep; 60(3):421-35. PubMed ID: 1474281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experience with WHO-recommended multidrug therapy (MDT) for multibacillary (MB) leprosy patients in the leprosy control program of the All Africa Leprosy and Rehabilitation Training Center in Ethiopia: appraisal of the recommended duration of MDT for MB patients.
    Becx-Bleumink M
    Int J Lepr Other Mycobact Dis; 1991 Dec; 59(4):558-68. PubMed ID: 1802938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of multidrug therapy on leprosy in Baroda district (Gujarat).
    Chopra NK; Agarwal JS; Pandya PG
    Indian J Lepr; 1989 Apr; 61(2):179-89. PubMed ID: 2746026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of multidrug therapy in paucibacillary leprosy in Singapore.
    Lim JT; Tan T
    Lepr Rev; 1993 Jun; 64(2):136-42. PubMed ID: 8341116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized controlled trial to compare cure and relapse rate of paucibacillary multidrug therapy with monthly rifampicin, ofloxacin, and minocycline among paucibacillary leprosy patients in Agra District, India.
    Kumar A; Girdhar A; Girdhar BK
    Indian J Dermatol Venereol Leprol; 2015; 81(4):356-62. PubMed ID: 26144850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Chemotherapy of Hansen's disease in Japan--present status].
    Goto M; Miyagi S; Takizawa H; Kitajima S
    Nihon Hansenbyo Gakkai Zasshi; 1998 Jul; 67(2):305-11. PubMed ID: 9785846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of anti-PGL-1 antibodies to monitor therapy regimes in leprosy patients.
    Zenha EM; Ferreira MA; Foss NT
    Braz J Med Biol Res; 2009 Oct; 42(10):968-72. PubMed ID: 19784481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The new challenges for chemotherapy research.
    Grosset J
    Lepr Rev; 2000 Dec; 71 Suppl():S100-4. PubMed ID: 11201863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A study on the effectiveness and safety of the WHO/MDT regimen in the northeast of Thailand; a prospective study, 1984-1996.
    Dasananjali K; Schreuder PA; Pirayavaraporn C
    Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):28-36. PubMed ID: 9207751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term follow up of multibacillary leprosy patients with high BI treated with WHO/MDT regimen for a fixed duration of two years.
    Shaw IN; Natrajan MM; Rao GS; Jesudasan K; Christian M; Kavitha M
    Int J Lepr Other Mycobact Dis; 2000 Dec; 68(4):405-9. PubMed ID: 11332283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.